minimal residual disease
Using MRD to Determine Duration of Targeted Therapy Improves Outcomes in CLL
Overall survival (OS) can be improved in fit patients with chronic lymphocytic leukemia (CLL) if the minimal ...
JANUARY 12, 2024
clonoSEQ Assay Authorized for Detection of MRD in Patients With MM and B-Cell ALL
The FDA has authorized use of the clonoSEQ Assay (Adaptive Biotechnologies) to monitor and detect minimal residual ...
OCTOBER 22, 2018
FDA Approves Blincyto for ALL Pts with Minimal Residual Disease
Blincyto is the first and only FDA-approved therapy for patients who have ALL that is in remission but who still ...
MARCH 29, 2018
In MRD, Cord Blood Posed As Best Transplant Option
In patients with acute leukemia or myelodysplastic syndrome who have minimal residual disease (MRD), cord blood ...
OCTOBER 6, 2016
Load more